# Naturo Aid Pharmaceutical Inc. · 99-39 · CANADA — FDA import alert red lists: firms subject to detention without physical examination

For Naturo Aid Pharmaceutical Inc., import alert is 99-39; country is CANADA; import alert name is Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded; product is Baby and Mom Pb15df; product code is 62 K B Y 08 Loperamide Hydrochloride (Anti-Peristaltic, Anti-Diarrheal), Human - Non/Rx Combination Ingredient, NEC; date published is 09/23/2026; address is 20285 Stewart Cres Unit 302 , Maple Ridge, British Columbia CANADA, verified against its source on 2026-09-30.

- **Firm:** Naturo Aid Pharmaceutical Inc. _(verified: appears in the quote below)_
- **Import alert:** 99-39
- **Import alert name:** Detention Without Physical Examination of Imported Food Products That Appear to Be Misbranded
- **Country:** CANADA _(verified: appears in the quote below)_
- **Address:** 20285 Stewart Cres Unit 302 , Maple Ridge, British Columbia CANADA _(verified: appears in the quote below)_
- **Date published:** 09/23/2026 _(verified: appears in the quote below)_
- **Product code:** 62 K B Y 08 Loperamide Hydrochloride (Anti-Peristaltic, Anti-Diarrheal), Human - Non/Rx Combination Ingredient, NEC _(verified: appears in its own passage below)_
- **Product:** Baby and Mom Pb15df _(verified: appears in its own passage below)_
- **FDA notes:** The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded within the meaning of Section 403(q) [21 U.S.C. § 343(q)] of the Federal Food, Drug, and Cosmetic Act, specifically under subsection 403(q)(5)(F), because the nutrition information on the product labeling fails to comply with the presentation and formatting requirements of 21 CFR 101.36. The article is subject to refusal of admission pursuant to section 801 (a)(3) in that it appears to be misbranded within the meaning of Section 403(a)(1) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. § 343(a)(1)] because its labeling and product name are false or misleading in any particular. Specifically, the labeling does not comply with 21 CFR 101.18. The article is subject to refusal of admission pursuant to section 801 (a)(3) in that it appears to be misbranded within the meaning of section 403(e)(2) of the Act [21 U.S.C. § 343(e)(2)] because the label does not bear an appropriate statement of net quantity of contents in accordance with 21 CFR 101.7. Specifically, the product label declares the net weight with the qualifying term "Approx." ("Net Wt. Approx. 3.17 oz (90 g)") in a manner that is not consistent with 21 CFR 101.7 (or 21 CFR 101.105) because it qualifies the net quantity statement and fails to provide an accurate statement of the quantity of contents. _(verified: appears in its own passage below)_

## What the source says

> Naturo Aid Pharmaceutical Inc. Date Published : 09/23/2026 20285 Stewart Cres Unit 302 , Maple Ridge, British Columbia CANADA

## Where each value comes from

This source states these in separate places, so each value is shown with the passage that states it.

### Product code

> 62 K B Y 08 Loperamide Hydrochloride (Anti-Peristaltic, Anti-Diarrheal), Human - Non/Rx Combination Ingredient, NEC Date Published: 09/23/2026 Desc: Baby and Mom Pb15df Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded within the meaning of Section 403(q) [21 U.S.C. § 343(q)] of the Federal Food, Drug, and Cosmetic Act, specifically under subsection 403(q)(5)(F), because the nutrition information on the product labeling fails to comply with the presentation and formatting requirements of 21 CFR 101.36. The article is subject to refusal of admission pursuant to section 801 (a)(3) in that it appears to be misbranded within the meaning of Section 403(a)(1) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. § 343(a)(1)] because its labeling and product name are false or misleading in any particular. Specifically, the labeling does not comply with 21 CFR 101.18. The article is subject to refusal of admission pursuant to section 801 (a)(3) in that it appears to be misbranded within the meaning of section 403(e)(2) of the Act [21 U.S.C. § 343(e)(2)] because the label does not bear an appropriate statement of net quantity of contents in accordance with 21 CFR 101.7. Specifically, the product label declares the net weight with the qualifying term "Approx." ("Net Wt. Approx. 3.17 oz (90 g)") in a manner that is not consistent with 21 CFR 101.7 (or 21 CFR 101.105) because it qualifies the net quantity statement and fails to provide an accurate statement of the quantity of contents.

### Product

> 62 K B Y 08 Loperamide Hydrochloride (Anti-Peristaltic, Anti-Diarrheal), Human - Non/Rx Combination Ingredient, NEC Date Published: 09/23/2026 Desc: Baby and Mom Pb15df Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded within the meaning of Section 403(q) [21 U.S.C. § 343(q)] of the Federal Food, Drug, and Cosmetic Act, specifically under subsection 403(q)(5)(F), because the nutrition information on the product labeling fails to comply with the presentation and formatting requirements of 21 CFR 101.36. The article is subject to refusal of admission pursuant to section 801 (a)(3) in that it appears to be misbranded within the meaning of Section 403(a)(1) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. § 343(a)(1)] because its labeling and product name are false or misleading in any particular. Specifically, the labeling does not comply with 21 CFR 101.18. The article is subject to refusal of admission pursuant to section 801 (a)(3) in that it appears to be misbranded within the meaning of section 403(e)(2) of the Act [21 U.S.C. § 343(e)(2)] because the label does not bear an appropriate statement of net quantity of contents in accordance with 21 CFR 101.7. Specifically, the product label declares the net weight with the qualifying term "Approx." ("Net Wt. Approx. 3.17 oz (90 g)") in a manner that is not consistent with 21 CFR 101.7 (or 21 CFR 101.105) because it qualifies the net quantity statement and fails to provide an accurate statement of the quantity of contents.

### FDA notes

> 62 K B Y 08 Loperamide Hydrochloride (Anti-Peristaltic, Anti-Diarrheal), Human - Non/Rx Combination Ingredient, NEC Date Published: 09/23/2026 Desc: Baby and Mom Pb15df Notes: The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded within the meaning of Section 403(q) [21 U.S.C. § 343(q)] of the Federal Food, Drug, and Cosmetic Act, specifically under subsection 403(q)(5)(F), because the nutrition information on the product labeling fails to comply with the presentation and formatting requirements of 21 CFR 101.36. The article is subject to refusal of admission pursuant to section 801 (a)(3) in that it appears to be misbranded within the meaning of Section 403(a)(1) of the Federal Food, Drug, and Cosmetic Act [21 U.S.C. § 343(a)(1)] because its labeling and product name are false or misleading in any particular. Specifically, the labeling does not comply with 21 CFR 101.18. The article is subject to refusal of admission pursuant to section 801 (a)(3) in that it appears to be misbranded within the meaning of section 403(e)(2) of the Act [21 U.S.C. § 343(e)(2)] because the label does not bear an appropriate statement of net quantity of contents in accordance with 21 CFR 101.7. Specifically, the product label declares the net weight with the qualifying term "Approx." ("Net Wt. Approx. 3.17 oz (90 g)") in a manner that is not consistent with 21 CFR 101.7 (or 21 CFR 101.105) because it qualifies the net quantity statement and fails to provide an accurate statement of the quantity of contents.

## Source

- https://www.accessdata.fda.gov/cms_ia/importalert_1144.html

Last verified: 2026-09-30. Review by: 2026-11-29.
Part of [FDA import alert red lists: firms subject to detention without physical examination](https://referencesource.org/fda-import-alert-red-list/).